SCHEMBL31033210

SCHEMBL31033210

Cc1nc(N2CC3CC3C2)ccc1Cn1cnc(C(=O)N[C@@H]2CCc3c2n[nH]c3C)n1

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21712975 1.00 KLKB1 (0.78) KLKB1
SCHEMBL21736710 0.85 KLKB1 (0.84) KLKB1
SCHEMBL22166247 0.85 KLKB1 (1.00) KLKB1
SCHEMBL21736722 0.84 KLKB1 (0.84) KLKB1
SCHEMBL31741522 0.83 KLKB1 (1.00) KLKB1
SCHEMBL22166232 0.83 KLKB1 (1.00) KLKB1
SCHEMBL21736758 0.83 KLKB1 (1.00) KLKB1
SCHEMBL31741470 0.82 KLKB1 (0.93) KLKB1
SCHEMBL21713008 0.82 KLKB1 (0.93) KLKB1
SCHEMBL21736716 0.81 KLKB1 (1.00) KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113039181-B Heteroaromatic carboxamide derivatives as inhibitors of plasma kallikrein 勃林格殷格翰国际有限公司 2024-08-13 CN disclosed